Iontophoretic delivery of apomorphine II: An in vivo study in patients with Parkinson's disease

Pharmaceutical Research

Volumn 14, Issue 12, 1997, Pages 1804-1810

  Van Der Geest, Ronald ^a,b   Van Laar, Teus ^c   Gubbens Stibbe, Josy M ^a   Boddé, Harry E ^a   Danhof, Meindert ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Janssen Pharmaceutics ^*  (Belgium)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apomorphine; Human; Iontophoresis; Parkinson's disease; Pharmacodynamics; Transdermal delivery

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ELECTRIC CURRENT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IONTOPHORESIS; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN CONDUCTANCE; SKIN IRRITATION; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANTIPARKINSON AGENTS; APOMORPHINE; CROSS-OVER STUDIES; FEMALE; HUMANS; IONTOPHORESIS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PARKINSON DISEASE; SKIN;

EID: 0031405246     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012152401715     Document Type: Article

References (25)

1. C. D. Marsden and J. D. Parkes. Lancet 1:292-296 (1976).
2. C. M. H. Stibe, A. J. Lees, and G. M. Stern. Lancet 1:871 (1987).
3. A. J. Lees. Fundam. Clin. Pharmacol. 7:121-128 (1993).
4. P. Pollak, A. S. Champay, M. Hommel, J. E. Peret, and A. L. Benebid. J. Neurol. Neurosurg. Psychiatry 52:544 (1989).
5. G. C. Cotzias, P. S. Papavasiliou, E. S. Tolosa, J. S. Mendez, and M. Bell-Midura. N. Engl. J. Med. 294:567-572 (1976).
6. A. J. Lees, J. L. Montastruc, N. Turjanski, O. Rascol, B. Kleedorfer, H. P. Saint-Paul, et al. J. Neurol. Neurosurg. Psychiatry 1:1440 (1989).
7. J. L. Montastruc, O. Rascol, J. M. Senard, V. Gaulano, H. Bagheri, G. Houin, et al. Clin Neuropharmacol. 14:432-437 (1991).
8. A. J. Hughes, S. Bishop, A. J. Lees, G. M. Stern, R. Webster, and M. Bovington. (letter) Lancet 337:118 (1991).
9. R. Kapoor, N. Turjanski, J. P. Frankel, B. Kleedorfer, A. J. Lees, and G. M. Stern, (letter). J. Neurol. Neurosurg. Psychiatry 1:1015 (1990)
10. B. Kleedorfer, N. Turjanski, R. Ryan, A. J. Lees, C. Milroy, and G. M. Stern. Neurology 41:761-762 (1991).
11. R. van der Geest, M. Danhof, and H. E. Boddé. Iontophoretic Delivery of Apomorphine: In Vitro Optimization and Validation. Pharm. Res. 14:1797-1802 (1997).
12. M. A. Ashburn, J. Streisand, J. Zhang, G. Love, M. Rowin, S. Niu, J. K. Kievit, J. R. Kroep, and M. J. Mertens. Anesthesiolgy 82:1146-53 (1995).
13. T. van Laar, R. van der Geest, M. Danhof, H. E. Boddé, P. H. Goossens, and R. A. C. Roos. Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's disease. Clin. Neuropharmacol. (in press).
14. C. D. Marsden and M. Schachter. Br. J. Clin. Pharmacol. 11:129-151 (1981).
15. R. van der Geest, P. Kruger, J. M. Gubbens-Stibbe, T. van Laar T, H. E. Boddé, and M. Danhof. Assay of R-apomorphine, S-apomorphine, a pocodeine, and isoapocodeine and their glucuronide and sulphate conjugates in plasma and urine of patients with Parkinson's disease. J. Chromatogr. (in press).
16. M. Gibaldi and D. Perrier. Non-compartmental analysis based on statistical moment theory. In: M. Gibaldi and D. Perrier (eds.), Pharmacokinetics, New York, Marcel Dekker 1982.
17. R. van der Geest, T. van Laar, P. P. Kruger, J. M. Gubbens-Stibbe, H. E. Boddé, R. A. C. Roos, and M. Danhof. Pharmacokinetics, enantiomer interconversion and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease. (submitted)
18. J. B. Phipps and J. R.F Gyory. Adv. Dr. Del. Rev. 9:137-76 (1992).
19. I. H. Patel and R. H. Levy. J. Pharmacokinet. Biopharm. 2:423-37 (1974).
20. P. Singh and M. S. Roberts. J. Pharm. Sci. 82:127-31 (1993a).
21. P. Signh and M. S. Roberts. J. Pharm. Sci. 82:873-879 (1993b).
22. A. J. Lees. Fundam. Clin. Pharmacol. 7:121-28 (1993).
23. K. Okabe, H. Yamaguchi, and Y. Kawai. J. Contr. Rel. 4:79-85 (1986).
24. S. Thysman, D. van Neste, and V. Préat. Skin Pharmacol. 8:229-236 (1995).
25. R. van der Geest, D. A. R. Elshove, M. Danhof, A. P. M. Lavrijsen, and H. E Boddé. J. Contr. Rel. 41:205-13 (1996).